Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161272
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-07
First Post:
2023-11-30
Brief Title:
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Sponsor:
Guangxi Medical University
Organization:
Guangxi Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-03-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-30
First Submit QC Date:
November 30 2023
Study First Post Date:
2023-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-30
Last Update Post Date:
2023-12-07
Last Update Post Date Type:
ACTUAL